Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 21 symbols : AZN save search
Pulmonary Drug Delivery Systems Global Market Forecasts to 2026: Focus on Metered-dose Inhalers, Dry Powered Inhalers, Soft Mist Inhalers and Nebulizers
Published: 2022-01-21 (Crawled : 12:30) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630
|
Health Technology
|
| O: -1.43%
H: 0.0%
C: -2.91%
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
drug liver system drug delivery
Irritable Bowel Syndrome Market to grow at a CAGR of 10.09% by 2025 |IBS-D Segment to be Significant for Revenue Generation|17000+ Technavio Reports
Published: 2022-01-21 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
ALPMY | News | $9.53 0.32% -1.11% 690K
|
Manufacturing
|
| O: -1.74%
H: 3.65%
C: 2.98%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
BHC | $8.45 -2.76% 0.0% 2.4M
|
Health Technology
|
| O: -2.86%
H: 0.0%
C: 0.0%
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
report syndros
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.